PINK:SPHDF

Santhera Pharmaceuticals Hldg Stock Forecast

etoro logo Buy SPHDF
*Your capital is at risk
$13.35
+0 (+0%)
At Close: Nov 17, 2025

SPHDF Performance

FAQ

What is the symbol for Santhera Pharmaceuticals Hldg Stock and on which exchange is it traded?
The symbol for Santhera Pharmaceuticals Hldg is SPHDF and it is traded on the PINK (Pink Sheets).

Should I buy or sell Santhera Pharmaceuticals Hldg Stock?
Santhera Pharmaceuticals Hldg holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Santhera Pharmaceuticals Hldg Stock?
Santhera Pharmaceuticals Hldg Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Santhera Pharmaceuticals Hldg Stock.

What's the current price of Santhera Pharmaceuticals Hldg Stock?
As of the end of day on the Nov 17, 2025, the price of an Santhera Pharmaceuticals Hldg (SPHDF) share was $13.35.

What is the 52-week high and low for Santhera Pharmaceuticals Hldg Stock?
The 52-week high for Santhera Pharmaceuticals Hldg Stock is $19.00 and the 52-week low is $9.42.

What is the market capitalization of Santhera Pharmaceuticals Hldg Stock?
As of the Nov 17, 2025, the market capitalization of Santhera Pharmaceuticals Hldg is 212.82M.

When is the next earnings date for Santhera Pharmaceuticals Hldg?
The upcoming earnings date for Santhera Pharmaceuticals Hldg is Apr 27, 2026.
Click to get the best stock tips daily for free!
ABOUT SANTHERA PHARMACEUTICALS HLDG
Santhera Pharmaceuticals Hldg
Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and commercializes medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the European Union and internationally. The company's lead pipeline candidate includes vamorolone, which is being developed as treatments for Duchenne muscular dystrophy (DMD). Its clinical stage pipeline also comprises lonodeles...
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE